It's nice to see some news rather than always relying on the CC. I hope this gives us a little shot in the arm as it will reach people who don't sit here all day! GLTA
Just fyi, this news is all over briefing.com. So we have that going for us.
Now the kicker. CDMO is currently the 2nd highest rated stock in the medical/biomed/biotech group in IBD's stock ranking. The med/biomed/biotech group is currently rated 55 out of the 197 groups IBD rates.
Might not mean much to other folks, but CDMO currently is carrying an A+ accumulation/distribution rating with an up/down volume of 2.4. To me, this is excellent and confirms what many of you have picked up on. It's hard to buy this stock at the current time.
Market Data 
Markets 
AI
